SEARCH BY

Issuer directory Issuer directory
KEYWORDS
COMPANIES / ISIN
TYPE OF INFORMATION
INDUSTRY

Start search  ADVANCED SEARCH

COMPARTMENTS / INDICES

France
America
Asia
Oceania
Africa
Europe

CAC 40 NEWS

FEEDS

My RSS My Google Microsoft Live My Yahoo

COMPANY SEARCH RESULT

Sanofi-Aventis: Click to view the issuer\'s details

Last update : 29/03/2019  >View issuer details

2020.09.25 | 07:30 | Permanent Information Releases / Notification of availability

English version HTML (w) Mail

puce Availability of the Q3 2020 Memorandum for modelling purposes - HTML (w)

2020.09.25 | 07:30 | Permanent Information Releases / Notification of availability

French version HTML (w) Mail

puce Mise en ligne du document «Q3 2020 Memorandum for modelling purposes» - HTML (w)

2020.09.22 | 07:00 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce Hart-Scott-Rodino waiting period expires for Sanofi’s acquisition of Principia Biopharma Inc. - HTML (w)

2020.09.18 | 07:00 | Permanent Information Releases / Appointments

English version HTML (w) Mail

puce Dr. Jean-Christophe Rufin appointed President of the Sanofi Espoir Corporate Foundation - HTML (w)

2020.09.18 | 07:00 | Permanent Information Releases / Appointments

French version HTML (w) Mail

puce Le Dr Jean-Christophe Rufin est nommé Président de la Fondation d’entreprise Sanofi Espoir - HTML (w)

2020.09.14 | 07:00 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce FDA grants Dupixent® (dupilumab) Breakthrough Therapy designation for eosinophilic esophagitis - HTML (w)

Pages : 1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 - 10 / Doc nb : 2956